Close Menu

In a session moderated by Phillip Sharp, professor at MIT's Institute for Integrative Cancer Research, principal investigators of the five Stand Up to Cancer grant-funded Dream Teams, researchers shared their progress. With SU2C, "we were challenged for finding teams out of a process that solicited — across the country — new ideas. And we used several criteria to look at these teams," Sharp told attendees of the American Association for Cancer Research's annual meeting. "Innovation: what could be done new, now?

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.